To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT07097441

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Ziauddin University (from the registry)
Registry
  • NCT NCT07097441
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07097441. Randomized; triple masking; primary purpose treatment. Start 2025-03-12 (actual); primary completion 2025-06-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
Condition
Tachycardia
Condition
Hypertension
Condition
Hypoxia
Condition
Hyperventilation
Condition
Residual Paralysis, Post Anesthesia
Intervention (Drug)
Placebo drug ( normal saline )
Intervention (Drug)
neostigmine (reversal agent)
Lead sponsor
Ziauddin University (class: other)

Record details

Record id
cardio:ct-nct07097441
Content hash
f43065e2f0a7a74f26d728a2f89cac295b2c80a76041f2259f63a6ee64728d3a